Skip to main content
Medical information Clinical review pending

Genetic Testing

Chlamydia Trachomatis RNA Detection Qualitative Test

Detect the presence of Chlamydia Trachomatis RNA using a sensitive Real Time PCR test. Essential for diagnosing this common STI and enabling timely treatment to prevent complications.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Urethral swab, cervical swab, urine sample, or vaginal swab. Confirm specific requirements with the laboratory before booking.
Results
Results are typically available within 36 hours via phone and 48 hours via email. Confirm with the laboratory before booking.
Preparation
No specific preparation is required for this test. However, follow any instructions provided by your healthcare provider or the laboratory regarding sample collection.
Test priceKSh 10,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Chlamydia Trachomatis RNA Detection Qualitative Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Symptoms suggestive of chlamydia (e.g., discharge, dysuria, pelvic pain)
  • ✓Screening for sexually active individuals, especially those with risk factors
  • ✓Diagnosis in cases of suspected STI exposure
  • ✓Screening during pregnancy
  • ✓Confirmation of infection after initial screening
  • ✓Monitoring treatment effectiveness (in specific clinical scenarios)
02

In plain language

What this test helps you understand

This test is used to detect the presence of Chlamydia Trachomatis RNA, aiding in the diagnosis of chlamydial infections. Early diagnosis allows for prompt treatment, reducing the risk of complications such as pelvic inflammatory disease, infertility, and ectopic pregnancy. It also helps prevent further transmission of the infection.
The Chlamydia Trachomatis RNA Detection Qualitative Test is a diagnostic tool used to identify Chlamydia Trachomatis, a common sexually transmitted infection (STI). This test uses Real Time PCR technology to detect RNA from the bacteria in samples like swabs or urine.

Untreated chlamydia can lead to serious health issues, including infertility and increased HIV risk. Early detection is crucial for effective treatment and preventing transmission. This test is recommended for sexually active individuals, especially those with symptoms or risk factors.

This test specifically detects the RNA of Chlamydia Trachomatis, confirming an active infection. Accurate diagnosis allows healthcare providers to recommend appropriate treatment.

Consider this test if you have symptoms like unusual discharge or pain during urination, have a history of STIs, are pregnant, or are sexually active, particularly with multiple partners.

Benefits include accurate diagnosis, prevention of complications, peace of mind, and facilitating effective treatment. Results are typically available within 48 hours via email and 36 hours via phone. A positive result requires medical consultation for treatment. Discuss your results with your healthcare provider.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific preparation is required for this test. However, follow any instructions provided by your healthcare provider or the laboratory regarding sample collection.
SampleUrethral swab, cervical swab, urine sample, or vaginal swab. Confirm specific requirements with the laboratory before booking.
MethodologyReal Time Polymerase Chain Reaction (PCR).
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects the presence of Chlamydia Trachomatis RNA but does not differentiate between active and past infections in all cases. A negative result does not completely rule out infection, especially if symptoms persist. Consult your healthcare provider for interpretation.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Chlamydia Trachomatis is a bacterium that causes a common sexually transmitted infection (STI). It can affect the genitals, rectum, and throat.
Early detection allows for prompt treatment, which can prevent serious long-term health complications like infertility, pelvic inflammatory disease, and increased risk of HIV transmission.
The test can be performed on various samples, including urethral swabs, cervical swabs, urine, and vaginal swabs. Your doctor will advise on the appropriate sample.
The Real Time PCR method used for this test is highly sensitive and specific, providing accurate results for detecting Chlamydia Trachomatis RNA.
A positive result indicates that Chlamydia Trachomatis RNA was detected in your sample, meaning you likely have an active infection. You should consult a healthcare provider immediately for treatment.
You can book the test by calling or WhatsApping +254711564616. Home sample collection services are available.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp